Through single-cell and single-gene analyses of colon cancer tumor samples, we identified a correlation between CISD2 and clinical outcomes, with elevated CISD2 expression conferring a protective effect against colon cancer and suppressing the immune system. The gene discussed is CISD2; the disease is colonic neoplasm.